Perrigo to Divest Dermacosmetics Business for Up to €327 Million
ALLEGAN, Mich., July 14, 2025 – Perrigo Company plc (NYSE: PRGO), a leading global provider of over-the-counter health and wellness solutions, today announced it has entered into a definitive agreement to divest its dermacosmetics business to an affiliate of LcurrentTarget, a leading private equity firm. The transaction is valued at up to €327 million, including an upfront payment and potential deferred consideration.
This strategic divestiture marks a significant step in Perrigo’s ongoing efforts to streamline its portfolio and focus on its core Consumer Self-Care business. The dermacosmetics business, which includes a range of skincare products, has been a part of Perrigo’s operations for several years.
“This agreement is a positive development for both Perrigo and our dermacosmetics business,” said Michelle Arnoult, Perrigo’s Executive Vice President and Chief Financial Officer. “Divesting this segment allows us to sharpen our strategic focus on the Consumer Self-Care categories where we see the greatest potential for growth and value creation. We are confident that under LcurrentTarget’s ownership, the dermacosmetics business will continue to thrive and serve its customers effectively.”
The divested business comprises a portfolio of well-established brands in the dermacosmetics market, known for their efficacy and consumer trust. The sale is expected to provide LcurrentTarget with a strong platform for future expansion and innovation within the skincare sector.
“We are excited about the opportunity to acquire this respected dermacosmetics business,” commented a representative from LcurrentTarget. “These brands have a strong heritage and a loyal customer base. We look forward to working with the talented team to further develop and grow the business, leveraging our expertise in operational enhancement and strategic brand building.”
The transaction is subject to customary closing conditions, including regulatory approvals, and is anticipated to be completed in the third quarter of 2025. Perrigo plans to use the net proceeds from the divestiture to further strengthen its balance sheet and support its ongoing strategic initiatives.
Perrigo remains committed to delivering high-quality, affordable self-care products to consumers worldwide. The company will continue to focus on its robust pipeline of innovation and strategic growth opportunities within its core business segments.
Perrigo Announces Agreement to Divest Dermacosmetics Business for up to €327 Million
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
PR Newswire Healthring published ‘Perrigo Announces Agreement to Divest Dermacosmetics Business for up to €327 Million’ at 2025-07-14 12:30. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.